FDA warns about seizures with MS drug Ampyra

WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Monday said people who take the multiple sclerosis drug Ampyra, from Biogen Idec Inc and Acorda Therapeutics Inc, have a higher risk of seizures when starting the treatment.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/AhDXLo5dFOo/us-fda-ampyra-idUSBRE86N04K20120724

phlebotomy certification classes government funded training courses phlebotomist training programs